|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$136M
|
–
|
–
|
–
|
|
|
2
|
FCPM III Services
Naarden,
Netherlands
|
$132M
|
+$108M
|
+11,831,461
|
New
|
|
|
3
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$117M
|
–
|
–
|
–
|
|
|
4
|
Viking Global Investors
Stamford,
Connecticut
|
$89.6M
|
–
|
–
|
–
|
|
|
5
|
RA Capital Management
Boston,
Massachusetts
|
$87.8M
|
-$10.4M
|
-1,136,000
|
-13%
|
|
|
6
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$32.1M
|
–
|
–
|
–
|
|
|
7
|
BVF Inc
San Francisco,
California
|
$17M
|
–
|
–
|
–
|
|
|
8
|
|
$15.5M
|
+$12.7M
|
+1,384,321
|
New
|
|
|
9
|
GMT Capital
Atlanta,
Georgia
|
$15.5M
|
–
|
–
|
–
|
|
|
10
|
Millennium Management
New York
|
$14.8M
|
+$2.58M
|
+281,319
|
+27%
|
|
|
11
|
Adage Capital Partners
Boston,
Massachusetts
|
$14.5M
|
+$916K
|
+100,000
|
+8%
|
|
|
12
|
Eversept Partners
New York
|
$4.18M
|
-$2.62M
|
-286,214
|
-43%
|
|
|
13
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$3.36M
|
+$474K
|
+51,726
|
+21%
|
|
|
14
|
|
$3.09M
|
-$61.2K
|
-6,687
|
-2%
|
|
|
15
|
Opaleye Management
Boston,
Massachusetts
|
$2.96M
|
+$2.43M
|
+265,388
|
New
|
|
|
16
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$2.14M
|
-$2.25M
|
-245,777
|
-56%
|
|
|
17
|
Affinity Asset Advisors
New York
|
$1.4M
|
–
|
–
|
–
|
|
|
18
|
Schonfeld Strategic Advisors
New York
|
$747K
|
+$20.2K
|
+2,200
|
+3%
|
|
|
19
|
Geode Capital Management
Boston,
Massachusetts
|
$529K
|
+$50.5K
|
+5,516
|
+13%
|
|
|
20
|
Marshall Wace
London,
United Kingdom
|
$379K
|
+$218K
|
+23,777
|
+234%
|
|
|
21
|
|
$319K
|
+$246K
|
+26,836
|
+1,577%
|
|
|
22
|
|
$256K
|
–
|
–
|
–
|
|
|
23
|
Citadel Advisors
Miami,
Florida
|
$235K
|
-$94.8K
|
-10,351
|
-33%
|
|
|
24
|
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$121K
|
+$90.4K
|
+9,875
|
+988%
|
|
|
25
|
Venture Visionary Partners
Sylvania,
Ohio
|
$112K
|
–
|
–
|
–
|
|
